International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Page(s): 488

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, pregabalin, gabapentinoid, voltage-dependent calcium channel inhibitor, anticonvulsant agent, seizure disorder, neuropathic pain, muscle pain, fibromyalgia, pain relief

Related Categories: EXCIPIENTS, FORMULATIONS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 488
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 486
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Shakshuki Ayah, Agu Remigius U	Nov/Dec 2019 Pg. 496-503
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance Jones Marty	Jan/Feb 2002 Pg. 4-6
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott	Mar/Apr 2015 Pg. 167-173
The Role of Sex Hormones on Fibromyalgia Pain Mediators Bramwell Bethany L	May/Jun 2010 Pg. 193-199
Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium Jones Marty	Jan/Feb 2000 Pg. 6-15
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management Rodriguez Franklin, Carvalho Maria, Banov Fabiana	Nov/Dec 2023 Pg. 468-473
Topical Treatment of Neuropathic Pain Vadaurri Vince	May/Jun 2008 Pg. 182-190
Update on Managing Neuropathic Pain McNulty Jack P, Muller George	May/Jun 2009 Pg. 182-190
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Return to Top